Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial (2018)
- Authors:
- Autor USP: LIMA, ANTONIO CARLOS PEDROSO DE - IME
- Unidade: IME
- DOI: 10.1186/s12962-018-0158-z
- Subjects: REAMOSTRAGEM BOOTSTRAP; DOENÇAS CARDIOVASCULARES; REVASCULARIZAÇÃO MIOCÁRDICA
- Keywords: coronary bypass surgery; prcutaneous coronary intervention; cost–beneft analysis; bare metal stent
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Cost Effectiveness and Resource Allocation
- ISSN: 1478-7547
- Volume/Número/Paginação/Ano: v.16, n. 55, p. 1-14, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BRANDÃO, Sara Michelly Gonçalves et al. Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial. Cost Effectiveness and Resource Allocation, v. 16, n. 55, p. 1-14, 2018Tradução . . Disponível em: https://doi.org/10.1186/s12962-018-0158-z. Acesso em: 19 fev. 2026. -
APA
Brandão, S. M. G., Rezende, P. C., Brunner-La Rocca, H. -P., Ju, Y. T., Lima, A. C. P. de, Takiuti, M. E., et al. (2018). Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial. Cost Effectiveness and Resource Allocation, 16( 55), 1-14. doi:10.1186/s12962-018-0158-z -
NLM
Brandão SMG, Rezende PC, Brunner-La Rocca H-P, Ju YT, Lima ACP de, Takiuti ME, Hueb W, Bocchi EA. Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial [Internet]. Cost Effectiveness and Resource Allocation. 2018 ;16( 55): 1-14.[citado 2026 fev. 19 ] Available from: https://doi.org/10.1186/s12962-018-0158-z -
Vancouver
Brandão SMG, Rezende PC, Brunner-La Rocca H-P, Ju YT, Lima ACP de, Takiuti ME, Hueb W, Bocchi EA. Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial [Internet]. Cost Effectiveness and Resource Allocation. 2018 ;16( 55): 1-14.[citado 2026 fev. 19 ] Available from: https://doi.org/10.1186/s12962-018-0158-z - Prognosis in severe heart failure due to Chagas' disease worse than heart failure due to idiopathic, ischaemic or hypertensive cardiomyopathy
- Massa ventricular esquerda em portadores de insuficiencia cardiaca
- A SAS macro for estimating transition probabilities in semiparametric models for recurrent events
- Association of HDL cholesterol and triglycerides with mortality in patients with heart failure
- Contiguity and irreconcilable nonstandard asymptotics of statistical tests
- Time-dependent coefficients in a multi-event model for survival analysis
- Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease
- Estimacao em modelos de sobrevivencia
- Chemical control of africanized honey bees (Apis mellifera) from the perspective of public health surveillance
- Modelo semiparamétrico de fragilidade Gama
Informações sobre o DOI: 10.1186/s12962-018-0158-z (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
2914775.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
